سعر بريفيبلوك بريميكسد 10 مجم/مل كيس 250 مل 2022

Ultra-short-acting IV cardioselective beta-1 blocker (esmolol) premixed 10 mg/mL 250 mL bag.

• Rapid control of ventricular rate in atrial fibrillation/flutter and perioperative tachycardia/hypertension (US label, same brand family).DailyMed (NLM), DrugBank

• Contraindicated in severe sinus bradycardia, heart block greater than first degree (without pacemaker), cardiogenic shock, and decompensated heart failure (US Brevibloc label).International label, same formulation · DailyMed (NLM)

• Risk of hypotension, bradycardia; must be administered with continuous monitoring in an appropriate setting (US label).International label, same formulation · DailyMed (NLM)

• Other negative chronotropes / antihypertensives (e.g. calcium channel blockers, digoxin)MajorAdditive bradycardia and hypotension possible; monitor closely (ingredient/class level from beta-blocker labelling).DailyMed (NLM), DrugBank

• Use in pregnancy only if potential benefit justifies potential risk; beta-blockers may cause fetal bradycardia (US labelling framework).International label, same formulation · DailyMed (NLM)

• Esmolol: Competitively blocks cardiac beta-1 receptors, slowing heart rate and reducing contractility with very short duration of action after IV infusion.